Search

Copyright of Urologia Journal is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The future approach of diagnostic imaging in urology follows the technological progress, which made the visualization of in vivo molecular processes possible. From anatomo-morphological diagnostic imaging and through functional imaging molecular radiology is reached. Based on molecular probes, imaging is aimed at assessing the in vivo molecular processes, their physiology and function at cellular level. The future imaging will investigate the complex tumor functioning as metabolism, aerobic glycolysis in particular, angiogenesis, cell proliferation, metastatic potential, hypoxia, apoptosis and receptors expressed by neoplastic cells. Methods for performing molecular radiology are CT, MRI, PET-CT, PET-MRI, SPECT and optical imaging. Molecular ultrasound combines technological advancement with targeted contrast media based on microbubbles, this allowing the selective registration of microbubble signal while that of stationary tissues is suppressed. An experimental study was carried out where the ultrasound molecular probe BR55 strictly bound to prostate tumor results in strong enhancement in the early phase after contrast, this contrast being maintained in the late phase. This late enhancement is markedly significant for the detection of prostatic cancer foci and to guide the biopsy sampling. The 124I-cG250 molecular antibody which is strictly linked to cellular carbonic anhydrase IX of clear cell renal carcinoma, allows the acquisition of diagnostic PET images of clear cell renal carcinoma without biopsy. This WG-250 (RENCAREX) antibody was used as a therapy in metastatic clear cell renal carcinoma. Future advancements and applications will result in early cancer diagnosis, personalized therapy that will be specific according to the molecular features of cancer and leading to the development of catheter-based multichannel molecular imaging devices for cystoscopy-based molecular imaging diagnosis and intervention.

A pulmonary nodule is a frequent and often incidental finding, and still represents a diagnostic challenge for radiologists. Although most solitary nodules are related to benign disease, some represent stage I lung cancers. and need to be distinguished from benign nodules in a cost-effective manner. The aim of diagnostic assessment should be to allow early treatment of small malignant nodules but avoid unnecessary biopsy or surgery, with their attendant risks, in patients with benign disease. The advent of Multislice Computed Tomography (MSCT) technology has sparked new interest in the non-invasive assessment of pulmonary nodules. Thanks to its ability to scan the whole thoracic volume with thinner collimations, this technology allows a more accurate identification and characterisation of pulmonary nodules, as well as the determination of perfusion patterns and growth rates. In this paper we present an algorithm for the diagnostic workup of incidentally detected small pulmonary nodules in subjects without known malignancy.

Nowadays, cardiac imaging is not part of the clinical routine for the radiologist. Multislice Computed Tomography (MSCT) with 4 rows allowed to start the non invasive evaluation of coronary arteries. The introduction of 16-row MSCT has significantly improved the performance and diagnostic accuracy of this technique, so far that MSCT angiography has been advocated as a potential clinical tool for the study of coronary artery disease. Therefore, it is mandatory to understand normal cardiac and coronary anatomy in order to evaluate the presence and severity of coronary artery disease. The anatomical visualisation provided by MSCT differs from the one of conventional coronary angiography because it is not a simple "lumenology" but it is capable to provide information on the vessel wall, until now only achieved by invasive techniques such as intravascular ultrasound or optical coherence tomography, and on neighbouring structures. Aim of this works is to provide the basics of anatomy of the vessels of the heart applied to MSCT.

Aim of this paper is to describe the technical main features that characterize Spiral Computed Tomography (CT) angiography. In particular, the technical features of the three main generations of single, four, and sixteen multislice scanners have been analised. Particular attention have been addressed to scan and reconstruction parameters, and to the geometry of contrast material related to angiographic scan. Guidelines for the different generations of CT scanner have been extracted to give the radiologist a platform for diagnostic questions.